英文名稱:PF-06761281 | CAS:1854061-19-0 |
保存條件: 0-4℃ | 純度規(guī)格: >98% |
產(chǎn)品類別: 制劑 抑制劑 |
Name: PF-06761281
CAS#: 1854061-19-0
Chemical Formula: C13H17NO6
Exact Mass: 283.1056
Molecular Weight: 283.28
Elemental Analysis: C, 55.12; H, 6.05; N, 4.94; O, 33.89
Description: PF-06761281 is an inhibitor of the sodium-coupled citrate transporter (NaCT or SLC13A5), which may be a target for tretment and prevention of metabolic disorders. The SLC13 transporters SLC13A2 (NaDC1), SLC13A3 (NaDC3), and SLC13A5 (NaCT) co-transport di- and tricarboxylates with multiple sodium ions into cells. PF-06761281 inhibits citrate uptake with an IC50 of 740 nM for NaCT in human hepatocytes. PF-06761281 has >25-fold in vitro selectivity for NaCT over NaDC1 and NaDC3 and was inactive in a selectivity panel of 65 targets.
IUPAC/Chemical Name: (2R)-2-Hydroxy-2-[2-(2-methoxy-5-methyl-3-pyridinyl)ethyl]-butanedioic acid
InChi Key: FGYMJXFSHBLHLW-CYBMUJFWSA-N
InChi Code: InChI=1S/C13H17NO6/c1-8-5-9(11(20-2)14-7-8)3-4-13(19,12(17)18)6-10(15)16/h5,7,19H,3-4,6H2,1-2H3,(H,15,16)(H,17,18)/t13-/m1/s1
SMILES Code: O=C(O)[C@](CCC1=CC(C)=CN=C1OC)(O)CC(O)=O
Appearance: Solid powder
成立日期 | 2017-02-16 (9年) | 注冊資本 | 100.000000萬人民幣 |
員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 500萬-1000萬 |
主營行業(yè) | 中間體,催化劑及助劑,生物化工,化學試劑,儀器耗材 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥497 |
VIP3年
|
TargetMol中國(陶術(shù)生物)
|
2025-02-28 | |
詢價 |
VIP12年
|
成都福爾斯特醫(yī)藥技術(shù)有限公司
|
2025-04-19 | |
詢價 |
VIP6年
|
武漢裕清嘉衡藥業(yè)有限公司
|
2025-04-19 | |
¥1800 |
VIP4年
|
上海雅吉生物科技有限公司
|
2025-04-19 |